Medical Glossary


Browse the glossary using this index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ALL

B

B cell

A type of white blood cell that makes antibodies. B cells are part of the immune system and develop from stem cells in the bone marrow. Also called B lymphocyte1.

 

   


Basal cell

A small, round cell found in the lower part (or base) of the epidermis, the outer layer of the skin1.

   



Base-pairs of DNA

Molecules called nucleotides, on opposite strands of the DNA double helix, that form chemical bonds with one another. These chemical bonds act like rungs in a ladder and help hold the two strands of DNA together. There are four nucleotides, or bases, in DNA: adenine (A), cytosine (C), guanine (G), and thymine (T). These bases form specific pairs (A with T, and G with C)1.

 

 


Benign

Not cancerous. Benign tumours may grow larger but do not spread to other parts of the body. Also called non-malignant1.

 

 



Benign tumour

A growth that is not cancer. It does not invade nearby tissue or spread to other parts of the body1.

   



Biomarker

A biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.1


Biomarker testing

A laboratory method that uses a sample of tissue, blood, or other body fluid to check for certain genes, proteins, or other molecules that may be a sign of a disease or condition, such as cancer. Biomarker testing can also be used to check for certain changes in a gene or chromosome that may increase a person’s risk of developing cancer or other diseases. Biomarker testing may be done with other procedures, such as biopsies, to help diagnose some types of cancer. It may also be used to help plan treatment, find out how well treatment is working, make a prognosis, or predict whether cancer will come back or spread to other parts of the body. Also called molecular profiling and molecular testing.1


Biopsy

The removal of cells or tissues by a surgeon for examination. A pathologist may then study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy1. 

 

 

Blood vessel

A tube through which the blood circulates in the body. Blood vessels include a network of arteries, arterioles, capillaries, venules, and veins1. 

   

BRAF

A gene that makes a protein that is involved in sending signals in cells and in cell growth. Mutated (changed) forms of the BRAF gene and protein have been found in many types of cancer. These changes can increase the growth and spread of cancer cells1.

 

 





BRAF gene

A gene that makes a protein called BRAF, which is involved in sending signals in cells and in cell growth. This gene may be mutated (changed) in some types of cancer, which causes a change in the BRAF protein. This can increase the growth and spread of cancer cells1.
  
   

BRAF inhibitor

A substance that blocks a protein called BRAF. BRAF is a kinase enzyme that helps control cell growth and signalling. It may be found in a mutated (changed) form in some types of cancer, including melanoma and colorectal cancer. Blocking mutated BRAF kinase proteins may help keep cancer cells from growing. Some BRAF kinase inhibitors are used to treat cancer1.

 

 

BRAF mutations

A specific mutation (change) in the BRAF gene, which makes a protein that is involved in sending signals in cells and in cell growth. This BRAF gene mutation may be found in some types of cancer, including melanoma and colorectal cancer. It may increase the growth and spread of cancer cells. Checking for this BRAF mutation in tumour tissue may help to plan cancer treatment1.


BRAF V600E mutation

A specific mutation (change) in the BRAF gene, which makes a protein that is involved in sending signals in cells and in cell growth. This BRAF gene mutation may be found in some types of cancer, including melanoma and colorectal cancer. It may increase the growth and spread of cancer cells. Checking for this BRAF mutation in tumour tissue may help to plan cancer treatment.1


BRAF-targeted therapy

See Targeted therapy1

Targeted therapy is medication that interferes with the function of abnormal molecules within cancer tumour cells that regulate their growth. The goal of targeted therapy is to shut down the mutated molecules to slow the growth of melanoma cells—without harming healthy tissue. About half of all melanoma cells have genetic mutations in the BRAF (pronounced bee-raf) protein. BRAF and MEK, another protein, are molecules that help regulate cell growth. A BRAF mutation triggers cells to develop abnormally and divide out of control. Targeted therapy drugs block the activity of the MEK protein and the mutated BRAF protein. In this way, the drugs slow or stop the growth and spread of melanoma2.

 

 



Breslow depth

A measure of how deeply a melanoma tumour has grown into the skin. The tumour thickness (depth) is usually measured from the top of the tumour to the deepest tumour cells. If the tumour is ulcerated (the skin is broken), it is measured from the base of the ulcer to the deepest tumour cells. Breslow depth is used to help determine the stage of cancer. Thicker tumours are linked with lower survival rates. Also called Breslow thickness1.
     

Breslow stage

Also termed Breslow depth.

A measure of how deeply a melanoma tumour has grown into the skin. The tumour thickness (depth) is usually measured from the top of the tumour to the deepest tumour cells. If the tumour is ulcerated (the skin is broken), it is measured from the base of the ulcer to the deepest tumour cells. Breslow depth is used to help determine the stage of cancer. Thicker tumours are linked with lower survival rates. Also called Breslow thickness1.
     

Breslow thickness

Also termed Breslow depth.

A measure of how deeply a melanoma tumour has grown into the skin. The tumour thickness (depth) is usually measured from the top of the tumour to the deepest tumour cells. If the tumour is ulcerated (the skin is broken), it is measured from the base of the ulcer to the deepest tumour cells. Breslow depth is used to help determine the stage of cancer. Thicker tumours are linked with lower survival rates. Also called Breslow thickness1.